Glofitamab (Columvi)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Glofitamab (Columvi), covering 2026-02-04 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL) [Phase 2]